334 related articles for article (PubMed ID: 27029038)
1. Current perspectives between metabolic syndrome and cancer.
Micucci C; Valli D; Matacchione G; Catalano A
Oncotarget; 2016 Jun; 7(25):38959-38972. PubMed ID: 27029038
[TBL] [Abstract][Full Text] [Related]
2. Visceral obesity, metabolic syndrome, insulin resistance and cancer.
Doyle SL; Donohoe CL; Lysaght J; Reynolds JV
Proc Nutr Soc; 2012 Feb; 71(1):181-9. PubMed ID: 22051112
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine and immune disequilibrium as a probable link between metabolic syndrome and carcinogenesis.
Hristova MG
Med Hypotheses; 2018 Sep; 118():1-5. PubMed ID: 30037593
[TBL] [Abstract][Full Text] [Related]
4. The link between the metabolic syndrome and cancer.
Braun S; Bitton-Worms K; LeRoith D
Int J Biol Sci; 2011; 7(7):1003-15. PubMed ID: 21912508
[TBL] [Abstract][Full Text] [Related]
5. [Role of obesity in colorectal carcinogenesis].
Hagymási K; Tulassay Z
Orv Hetil; 2007 Dec; 148(51):2411-6. PubMed ID: 18055394
[TBL] [Abstract][Full Text] [Related]
6. Contribution of RAGE axis activation to the association between metabolic syndrome and cancer.
Garay-Sevilla ME; Gomez-Ojeda A; González I; Luévano-Contreras C; Rojas A
Mol Cell Biochem; 2021 Mar; 476(3):1555-1573. PubMed ID: 33398664
[TBL] [Abstract][Full Text] [Related]
7. The midlife transition and the risk of cardiovascular disease and cancer Part I: magnitude and mechanisms.
Kase NG; Gretz Friedman E; Brodman M; Kang C; Gallagher EJ; LeRoith D
Am J Obstet Gynecol; 2020 Dec; 223(6):820-833. PubMed ID: 32497614
[TBL] [Abstract][Full Text] [Related]
8. Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review.
Biadgo B; Abebe M
Korean J Gastroenterol; 2016 Apr; 67(4):168-77. PubMed ID: 27112242
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review.
Giovannucci E
Am J Clin Nutr; 2007 Sep; 86(3):s836-42. PubMed ID: 18265477
[TBL] [Abstract][Full Text] [Related]
10. Obesity and metabolic syndrome: pathological effects on the gastrointestinal tract.
Feakins RM
Histopathology; 2016 Apr; 68(5):630-40. PubMed ID: 26599607
[TBL] [Abstract][Full Text] [Related]
11. Targeting inflammation in metabolic syndrome.
Welty FK; Alfaddagh A; Elajami TK
Transl Res; 2016 Jan; 167(1):257-80. PubMed ID: 26207884
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
[TBL] [Abstract][Full Text] [Related]
13. [Correlations of insulin resistance and neoplasms].
Suba Z; Ujpál M
Magy Onkol; 2006; 50(2):127-35. PubMed ID: 16888676
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and risk of subsequent colorectal cancer.
Pais R; Silaghi H; Silaghi AC; Rusu ML; Dumitrascu DL
World J Gastroenterol; 2009 Nov; 15(41):5141-8. PubMed ID: 19891012
[TBL] [Abstract][Full Text] [Related]
15. Nutrition, metabolic factors and cancer risk.
Dossus L; Kaaks R
Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):551-71. PubMed ID: 18971118
[TBL] [Abstract][Full Text] [Related]
16. Obesity modulation - the role in carcinogenesis.
Legakis I; Syrigos K
Anticancer Agents Med Chem; 2010 Jul; 10(6):481-90. PubMed ID: 20698826
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome as a peculiar target for management of prostate cancer patients.
Conteduca V; Di Lorenzo G; Bozza G; Ardito R; Aieta M
Clin Genitourin Cancer; 2013 Sep; 11(3):211-20. PubMed ID: 23701880
[TBL] [Abstract][Full Text] [Related]
18. Obesity and cancer: local and systemic mechanisms.
Iyengar NM; Hudis CA; Dannenberg AJ
Annu Rev Med; 2015; 66():297-309. PubMed ID: 25587653
[TBL] [Abstract][Full Text] [Related]
19. [The metabolic syndrome and type-2 diabetes mellitus as conditions predisposing for malignant tumors].
Halmos T; Suba I
Orv Hetil; 2008 Dec; 149(51):2403-11. PubMed ID: 19073451
[TBL] [Abstract][Full Text] [Related]
20. New advances on the functional cross-talk between insulin-like growth factor-I and estrogen signaling in cancer.
Bartella V; De Marco P; Malaguarnera R; Belfiore A; Maggiolini M
Cell Signal; 2012 Aug; 24(8):1515-21. PubMed ID: 22481093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
